Several studies also reveal that point mutation of the TLR9 gene (TLR9P915H, lacking MyD88) culminate to a more prominent decline in SLE disease progression when compared to wild-type populations [150]. This evidence concerns the gene TLR9 and systemic lupus erythematosus.